Dr. Pastagia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
260 E. Grand Avenue
South San Francisco, CA 94080Phone+1 646-667-9925
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 2006 - 2008
Boston University Medical CenterResidency, Internal Medicine, 2002 - 2005
State University of New York Downstate Medical Center College of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2006 - 2017
Clinical Trials
- AZD8108 SAD/MAD in Healthy Volunteers Start of enrollment: 2014 Nov 01
- A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection Start of enrollment: 2017 Jul 07
Publications & Presentations
PubMed
- 10 citationsDifferences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in six New York Community Health Centers.N. Piper Jenks, M. Pardos de la Gandara, Brianna D’Orazio, J. Correa da Rosa, Rhonda G. Kost
Travel Medicine and Infectious Disease. 2016-11-01 - 139 citationsA Novel Chimeric Lysin Shows Superiority to Mupirocin for Skin Decolonization of Methicillin-Resistant and -Sensitive Staphylococcus aureus StrainsMina Pastagia, Chad W. Euler, Peter Chahales, Judilyn Fuentes-Duculan, James G. Krueger
Antimicrobial Agents and Chemotherapy. 2011-02-01 - 7 citationsSafety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults.Edward Gane, Mina Pastagia, Ullrich Schwertschlag, An De Creus, Christian Schwabe
Antiviral Therapy. 2021-05-01
Press Mentions
Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas Aeruginosa InfectionJuly 12th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
